NSPR Stock Analysis: Buy, Sell, or Hold?
NSPR - InspireMD, Inc.
$0.70
0.04 (6.47%)
▲
5d:
-1.77%
30d:
-20.7%
90d:
-59.69%
BUY
HIGH Confidence
Analysis Updated: Jun 26, 2026 12:00 AM ET
Earnings: Aug 03, 2026
Get Alerted When NSPR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: NSPR shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
✅ BUY SIGNAL: NSPR shows strong fundamentals and good volume confirmation. Solid entry point despite oversold pricing.
In-depth Analysis How we analyze
Valuation Analysis: NSPR is currently trading at $0.70, which is considered oversold relative to its 30-day fair value range of $0.72 to $0.97.
Technical Outlook: Technically, NSPR is in a strong downtrend. The price is currently testing key support at $0.76. A bounce from this level would confirm strength, while a break below could signal further downside. The stock is showing strong short-term momentum, up 6.5% recently.
Market Sentiment: NSPR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $3.67 (+459.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, NSPR is in a strong downtrend. The price is currently testing key support at $0.76. A bounce from this level would confirm strength, while a break below could signal further downside. The stock is showing strong short-term momentum, up 6.5% recently.
Market Sentiment: NSPR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $3.67 (+459.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.72 -
$0.97
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
100.0%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.5%)
- BULLISH: Trading 459.8% below Wall St target ($3.67)
Trading Range Analysis
30-Day Trading Range
$0.72 -
$0.97
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.76
Resistance Level
$1.04
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.07
Wall Street Target
$3.67
(+459.8%)
Revenue Growth (YoY)
122.2%
Share & Embed Analysis
Last updated: June 26, 2026 3:03 PM ET
Data refreshes hourly during market hours. Next update: 4:03 PM
Data refreshes hourly during market hours. Next update: 4:03 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NSPR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
10
Sells
Net
INSIDERS SELLING
Recent Transactions
Shane Thomas Gleason
SELL
2000 shares
2026-02-02
Shane Thomas Gleason
SELL
2900 shares
2026-01-30
Shane Thomas Gleason
SELL
5000 shares
2026-01-29
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$77 | 66 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 65 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 55 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 68 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$242 | 65 BUY |
